ALK enters the final stretch before its July 23 earnings date with a fresh analyst upgrade, options positioning at its most bullish in months, and a short base that continues to shrink — three signals pointing in the same direction, even if the 10% float short keeps the bear case alive.
The clearest new development this week is on the Street. UBS raised its price target to $62 from $56 on Tuesday, keeping its Buy rating — the most concrete expression of bullish conviction from a bellwether firm since the stock's month-long recovery began. That target sits well above the current price of $49.21, and the Street mean of $57.88 implies roughly 18% upside from here. The direction of travel among analysts has shifted. Earlier in the year, cuts dominated — Citigroup downgraded to Sell in May with a $32 target, and several firms trimmed targets through April. The UBS move is the first meaningful upward revision in weeks, and it lands while the stock is trading above most of those April-era targets. One exception remains: Citigroup's $32 Sell is a significant outlier against a field where Buy-side targets cluster in the $55–$62 range.
Options positioning reinforces the bullish tilt. The put/call ratio has dropped to 0.33, more than 1.7 standard deviations below its 20-day average of 0.39 — the most call-heavy skew in the past year. This is a directional shift from earlier in the spring, when the PCR was running above 0.55. Demand for upside exposure is building. Meanwhile, the lending market remains relaxed: availability is at 292% of outstanding short interest, meaning roughly three shares are available to borrow for every two currently lent out. Borrowing costs are negligible at 0.55%, down slightly on the week. There is no meaningful squeeze pressure, and new short positions face no structural friction to enter.
Short interest itself tells a modestly constructive story. The position has trimmed about 2% over the past month to 10.3% of the free float — still elevated, but moving in the right direction for longs. This week's tick-up of around 0.2% is noise against the larger downtrend since late May's peak. The short score of 57.8 is mid-range and has been drifting rather than spiking, consistent with a position that is consolidating rather than building. Among peers, this week's moves were broadly positive — ALGT led with an 11.6% gain, AAL added 7.3%, and DAL rose 3.4%. ALK's flat week relative to those names suggests some of the prior outperformance is digesting, though the stock remains up 19% over the past month.
Valuation has re-rated alongside the price. The P/E has expanded roughly 3 points over the past 30 days to 18.6x, and EV/EBITDA has ticked down to 6.1x as earnings estimates improve. The 30-day forward EPS momentum rank is in the 98th percentile — the strongest reading in the scoring framework — reflecting a sharp upward revision cycle that began in late spring. The 90-day EPS momentum rank, at just 4, captures how bad things looked before the turn, and provides the baseline against which the current improvement looks so dramatic.
Recent earnings history adds a note of caution. The last four prints produced negative one-day moves in three of four instances, with five-day moves negative in all four. The April results knocked the stock 8.7% in a session and 10.9% over the following week. Whether July 23 follows that pattern or marks the point where improved guidance changes the reaction function is what the market will be pricing into options positioning between now and then.
See the live data behind this article on ORTEX.
Open ALK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
